AWM
KYNB

Avior Wealth Management’s Kyntra Bio KYNB Stock Holding History

Avior Wealth Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$82 – 2773
2024
Q1 		$82 Buy
+1
New +$43 ﹤0.01% 3270

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Avior Wealth Management's KYNB Position: Q2 2024 in Review

Avior Wealth Management sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 1 share — an estimated $82 sold.

Avior Wealth Management first reported a position in KYNB in Q1 2024 and held it in 1 quarter. The position peaked at $82 in Q1 2024. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • Avior Wealth Management reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • Avior Wealth Management sold 1 Kyntra Bio share in Q2 2024, an estimated $82.
  • Avior Wealth Management first reported a position in Kyntra Bio in Q1 2024 and held it in 1 quarter.
  • Avior Wealth Management's Kyntra Bio position peaked at $82 in Q1 2024.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.